Terns Pharmaceuticals Inc (TERN)
EBITDA Growth
-20.89%
TTM · Period ending:
TERN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-20.89%period ending
Latest reported-20.89%period ending
TERN TTM EBITDA YoY % (-17.30% → -20.89%)
Year-over-year change
High-resolution chart · PNG
TERN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -20.889% | |
| -7.7018% | |
| 4.1368% | |
| 0.6408% | |
| 1.5636% | |
| -3.9361% | |
| -34.003% | |
| -34.7041% | |
| -51.1153% | |
| -45.7069% | |
| -34.5344% | |
| -34.8402% | |
| -19.9833% | |
| -30.1231% | |
| -28.0523% | |
| -22.4295% | |
| -34.1378% | |
| -17.3033% |